Lisata Therapeutics's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Lisata Therapeutics (NASDAQ:LSTA) is expected to report a Q4 EPS of $-0.89 on Thursday, 2024-02-29. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for the next quarter. The company's past earnings performance shows a history of beating EPS estimates, which has sometimes led to significant share price movements. Shares were trading at $3.22 as of February 27, with a 5.1% increase over the last 52 weeks.
February 28, 2024 | 7:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Lisata Therapeutics is anticipated to report a Q4 EPS of $-0.89, with a focus on beating this estimate and providing positive future guidance. The stock has shown positive movement in response to past earnings beats.
Given Lisata Therapeutics' history of beating EPS estimates and the subsequent positive stock price movements, a similar outcome could be expected if they beat the Q4 estimate and provide optimistic guidance. The stock's recent performance and the historical response to earnings beats suggest a potential positive short-term impact.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100